Securities Code: 300702
Securities Abbreviation: Tianyu Shares
Announcement No.: 2026-065
Zhejiang Tianyu Pharmaceutical Co., Ltd.
Announcement on the Approval of a Drug by a Wholly-Owned Subsidiary
The Board of Directors and all directors of the Company guarantee that the information contained in this announcement is free from false representations, misleading statements, or material omissions, and that they shall bear individual and joint legal responsibility for the authenticity, accuracy, and completeness of the content.
Zhejiang Tianyu Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") announces that its wholly-owned subsidiary, Zhejiang Nuode Pharmaceutical Co., Ltd. (hereinafter referred to as "Nuode Pharmaceutical"), recently received the "Drug Registration Certificate" for Brexpiprazole Tablets issued by the National Medical Products Administration (hereinafter referred to as the "NMPA"). The relevant situation is hereby announced as follows: